Medication info
Memantine 10 mg Tablets (Memantine Hydrochloride)

Memantine 10 mg Tablets (Memantine Hydrochloride)

Prescription medicationTabletOral
Ingredient · strength
Memantine Hydrochloride›10mg / 1 tablet
Manufacturer / importer
Dasan Pharmaceutical Co., Ltd.
Appearance
White rectangular film-coated tablet
Packaging
30 tablets/bottle, 100 tablets/bottle
Approval status
Active

MFDS item code 202001720 · Approved 2020.03.12 · Insurance code 678601630

Summary

Main use
Treatment of moderate to severe Alzheimer's disease
Who takes it
Adults
Adult dose
This medicine is administered orally once daily, at the same time each day. If needed, it may be administered twice daily. It may be taken with or without food. The maximum daily dose is 20mg. To minimize the risk of adverse reactions, increase the dose by 5mg per week over the first 3 weeks as follows until the maintenance dose is reached. Week 1 (Days 1–7) Administer 5mg daily for 7 days. Week 2 (Days 8–14) Administer 10mg daily for 7 days. Week 3 (Days 15–21) Administer 15mg daily for 7 days. From Week 4 onward Administer 20mg daily. The recommended maintenance dose is 20mg daily. The recommended dose for older patients aged 65 years or older is 20mg daily. No dose adjustment is needed in patients with mild renal impairment (creatinine clearance: 50-80 mL/min). In patients with moderate renal impairment (creatinine clearance 30-49 mL/min), reduce the daily dose to 10mg. If well tolerated after at least 7 days of treatment, the dose may be increased to 20mg daily according to the standard dose-increase schedule. In patients with severe renal impairment (creatinine clearance 5-29 mL/min), reduce the daily dose to 10mg. No dose adjustment is needed in patients with mild or moderate hepatic impairment (Child-Pugh A, Child-Pugh B). Because there are no data on the use of memantine in patients with severe hepatic impairment, it is preferable not to administer this medicine.

Ingredients

Manufacturer
Dasan Pharmaceutical Co., Ltd.

Efficacy & effects

Treatment of moderate to severe Alzheimer's disease

  • Alzheimer's disease
View approved original text

This medication is used for the treatment of moderate to severe Alzheimer's disease.

How to take

Adult dose

This medicine is administered orally once daily, at the same time each day. If needed, it may be administered twice daily. It may be taken with or without food. The maximum daily dose is 20mg. To minimize the risk of adverse reactions, increase the dose by 5mg per week over the first 3 weeks as follows until the maintenance dose is reached. Week 1 (Days 1–7) Administer 5mg daily for 7 days. Week 2 (Days 8–14) Administer 10mg daily for 7 days. Week 3 (Days 15–21) Administer 15mg daily for 7 days. From Week 4 onward Administer 20mg daily. The recommended maintenance dose is 20mg daily. The recommended dose for older patients aged 65 years or older is 20mg daily. No dose adjustment is needed in patients with mild renal impairment (creatinine clearance: 50-80 mL/min). In patients with moderate renal impairment (creatinine clearance 30-49 mL/min), reduce the daily dose to 10mg. If well tolerated after at least 7 days of treatment, the dose may be increased to 20mg daily according to the standard dose-increase schedule. In patients with severe renal impairment (creatinine clearance 5-29 mL/min), reduce the daily dose to 10mg. No dose adjustment is needed in patients with mild or moderate hepatic impairment (Child-Pugh A, Child-Pugh B). Because there are no data on the use of memantine in patients with severe hepatic impairment, it is preferable not to administer this medicine.

Precautions

This medication should not be used by patients who are allergic to any of its ingredients. It is also safe not to administer it to patients with severely impaired liver function or very poor kidney function. Patients with epilepsy or those who have experienced seizures in the past, as well as individuals with a predisposition to epilepsy, should use this medication very cautiously. Additionally, taking this medication in combination with other drugs that have similar effects can exacerbate central nervous system side effects, so concurrent use should be avoided. Careful monitoring is advised if there are changes in urine acidity (pH) or dietary habits that may affect it. Patients with recent heart disease or uncontrolled hypertension should exercise caution as the safety of this medication has not been sufficiently verified in these situations. While taking this medication, symptoms such as dizziness, headache, constipation, drowsiness, and hypertension may occur, so it is advisable to consult a medical professional if any abnormal symptoms appear. This medication can interact with several other drugs, so it's important to disclose any other medications being taken, especially when used in conjunction with specific muscle relaxants, antipsychotic medications, or anticoagulants. Women who are pregnant or may become pregnant should carefully consider the risks and benefits of using this medication, and it is recommended to discontinue breastfeeding if nursing. Children and adolescents under the age of 18 should preferably not use this medication, as its safety and effectiveness have not been adequately established for this age group. In case of overdose, central nervous system symptoms such as confusion, drowsiness, dizziness, hallucinations, and seizures may occur, and it is vital to seek appropriate medical treatment immediately. Lastly, this medication should be stored out of reach of children, and it is advisable to avoid transferring it to another container.

Side effects

  • Dizziness
  • headache
  • constipation
  • drowsiness
  • hypertension
  • fungal infection
  • drug hypersensitivity reaction
  • confusion
  • hallucination
  • psychotic reaction
Show 23 more
  • balance disorder
  • gait abnormality
  • seizure
  • heart failure
  • venous thrombosis/thromboembolism
  • respiratory distress
  • vomiting
  • pancreatitis
  • elevated liver function test results
  • hepatitis
  • fatigue
  • nonspecific fatigue
  • weakness
  • diarrhea
  • anxiety
  • aggression
  • stupor
  • unconsciousness
  • double vision
  • restlessness
  • psychosis
  • visual hallucination
  • coma

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a sealed container to protect it from air and moisture, ideally at room temperature between 1 and 30 degrees Celsius. Storing it this way will help maintain the medication's effectiveness and ensure safe use.

Appearance and packaging

Appearance

White rectangular film-coated tablet

Package unit

30 tablets/bottle, 100 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.